This review highlights the current state of antiarrhythmic drug therapy for atrial fibrillation, emphasizing the roles of both rate and rhythm control strategies.
Supports pharmacological AF strategies; confirms consensus while leaving optimal selection open for trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alessandro Capucci (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: